Prosight Management, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$609.8M
Q ending 2026-03-31
Prior quarter
$483.9M
Q ending 2025-12-31
Change
+26.0% QoQ · +100.4% YoY
Positions
46
reported holdings
Largest positions
All 46 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Nektar Therapeutics | NKTR | Shares | $52.9M | 735K |
| Boston Scientific Corp | BSX | Shares | $49.9M | 796K |
| Janux Therapeutics Inc | JANX | Shares | $49.3M | 3.5M |
| Procept Biorobotics Corp | PRCT | Shares | $48.6M | 1.9M |
| Galapagos Nv | LKFT | Shares | $46.5M | 1.6M |
| Genedx Holdings Corp | WGS | Shares | $33.6M | 523K |
| Shattuck Labs Inc | STTK | Shares | $32.2M | 5.0M |
| Adc Therapeutics Sa | Shares | $31.1M | 8.3M | |
| Kura Oncology Inc | KURA | Shares | $27.3M | 3.4M |
| Alnylam Pharmaceuticals Inc | ALNY | Shares | $25.1M | 76K |
| Meiragtx Hldgs Plc | Shares | $22.8M | 2.6M | |
| Alkermes Plc | Shares | $18.2M | 514K | |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $18.0M | 770K |
| Veeva Sys Inc | VEEV | Shares | $15.2M | 86K |
| Zymeworks Inc | ZYME | Shares | $13.5M | 539K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $12.7M | 350K |
| Abivax Sa | ABVX | Shares | $11.7M | 105K |
| Concentra Group Holdings Par | CON | Shares | $10.8M | 506K |
| Terns Pharmaceuticals Inc | 430 | Shares | $10.7M | 202K |
| Phreesia Inc | PHR | Shares | $9.2M | 1.1M |
| Onkure Therapeutics Inc | OKUR | Shares | $8.9M | 2.2M |
| Corbus Pharmaceuticals Hldgs | CRBP | Shares | $6.5M | 697K |
| Schrodinger Inc | SDGR | Shares | $5.8M | 511K |
| Emergent Biosolutions Inc | EBS | Shares | $5.3M | 639K |
| Roivant Sciences Ltd | Shares | $5.0M | 180K | |
| Orthopediatrics Corp | KIDS | Shares | $4.8M | 302K |
| Immunovant Inc | IMVT | Shares | $4.4M | 176K |
| Icu Med Inc | ICUI | Shares | $3.5M | 27K |
| Tectonic Therapeutic Inc | TECX | Shares | $2.5M | 80K |
| Rocket Pharmaceuticals Inc | RCKT | Shares | $2.4M | 684K |
| Upstream Bio Inc | UPB | Shares | $2.2M | 241K |
| Pliant Therapeutics Inc | PLRX | Shares | $2.1M | 1.7M |
| Omeros Corp | OMER | Shares | $1.8M | 175K |
| Intuitive Surgical Inc | ISRG | Shares | $1.8M | 4K |
| An2 Therapeutics Inc | ANTX | Shares | $1.8M | 516K |
| Adicet Bio Inc | ACET | Shares | $1.7M | 250K |
| Regenxbio Inc | RGNX | Shares | $1.7M | 200K |
| Coya Therapeutics Inc | COYA | Shares | $1.7M | 420K |
| Viking Therapeutics Inc | VKTX | Shares | $1.5M | 45K |
| Irhythm Holdings Inc | IRTC | Shares | $1.2M | 10K |
| Trueblue Inc | TBI | Shares | $974K | 249K |
| Immuneering Corp | IMRX | Shares | $650K | 123K |
| Palvella Therapeutics Inc Ne | PVLA | Shares | $623K | 5K |
| Novocure Ltd | Shares | $549K | 50K | |
| Rein Therapeutics Inc | RNTX | Shares | $535K | 412K |
| Transmedics Group Inc | TMDX | Shares | $497K | 5K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.